Arich Enterprise Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020
November 10, 2020 at 01:09 pm
Share
Arich Enterprise Co., Ltd. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was TWD 317.922 million compared to TWD 312.711 million a year ago. Operating income was TWD 6.676 million compared to TWD 14.086 million a year ago. Net income was TWD 4.374 million compared to TWD 10.720 million a year ago. Basic earnings per share was TWD 0.06 compared to TWD 0.24 a year ago. For the nine months, sales was TWD 1,075.820 million compared to TWD 912.539 million a year ago. Operating income was TWD 41.479 million compared to TWD 49.974 million a year ago. Net income was TWD 40.859 million compared to TWD 47.009 million a year ago. Basic earnings per share was TWD 0.66 compared to TWD 1.05 a year ago. Diluted earnings per share was TWD 0.65 compared to TWD 1.05 a year ago.
Arich Enterprise Co., Ltd. is a Taiwan-based company principally engaged in the sales and marketing of pharmaceuticals, as well as the provision of the related logistics services. The Company is principally engaged in the sale and marketing of prescription drugs for gynaecology, obstetrics, urinary, derma and ophthalmology use; guideline drugs for hair breeding, intestines and stomach and smoking quit, as well as health consumer goods for oral health, daily consuming and beauty care, among others. The Company also provides distribution and logistics services for prescription drugs, guideline drugs, restriction drugs, cold chain drugs, clinical trial drugs and healthcare products, among others. The Company operates its business mainly within domestic market.
ARICH ENTERPRISE CO., LTD. 
